Skip to main content

Park National Corporation (PRK) Stock Forecast

Data as of Aug 7, 2026

Financial Services · Current price $205.52 ()

Consensus Target
$189.00
Upside
+4.1%
Analysts
4
Rating
Hold(3.00)

Price Target Range

Low $189.00High $189.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold3
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

PRK vs Sector & Market

MetricPRKFinancial Services AvgLarge Cap Avg
Analyst Rating3.002.522.42
Analyst Count4818
Target Upside+4.1%+95.1%+17.2%
P/E Ratio18.93-4.7535.26

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$169M$173M$176M1
2026-12-31$169M$173M$177M1
2027-03-31$167M$171M$175M1
2027-06-30$170M$174M$178M1
2027-09-30$171M$174M$178M1
2027-12-31$172M$176M$180M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$3.03$3.12$3.211
2026-12-31$3.08$3.17$3.261
2027-03-31$3.01$3.10$3.181
2027-06-30$3.09$3.18$3.271
2027-09-30$3.02$3.11$3.201
2027-12-31$3.04$3.13$3.221

Frequently Asked Questions

What is the analyst consensus for PRK?

The consensus among 4 analysts covering Park National Corporation (PRK) is Hold with an average price target of $189.00.

What is the highest price target for PRK?

The highest analyst price target for PRK is $189.00.

What is the lowest price target for PRK?

The lowest analyst price target for PRK is $189.00.

How many analysts cover PRK?

4 analysts have issued ratings for Park National Corporation in the past 12 months.

Is PRK a buy or sell right now?

Based on 4 analyst ratings, PRK has a consensus rating of Hold (3.00/5) with a +4.1% upside to the consensus target of $189.00.

What are the earnings estimates for PRK?

Analysts estimate PRK will report EPS of $3.12 for the period ending 2026-09-30, with revenue estimated at $173M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.